MetasTx, LLC

Headquarters

Pittsburgh, PA

MetasTx is a precision oncology platform developing next-generation KIT inhibitors and a companion diagnostic to prevent prostate cancer metastasis. The company focuses on inhibiting PAK1 to block epithelial-to-mesenchymal transition (EMT) and drug resistance in cancer cells.

• NovocureNovocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. The company's commercialized products are approved for treating adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma, and pleural mesothelioma.PORTSMOUTH, NH
• Molecular Targeting Technologies, IncMolecular Targeting Technologies, Inc. (MTTI) is a clinical-stage biotech company developing targeted radiotherapeutics and diagnostics for rare cancers using the EvaThera theranostics platform based on Evans blue dye technology.WEST CHESTER, PA
• Duo OncologyDuo Oncology is a clinical-stage biotechnology company that develops and manufactures ultrasmall nanomedicines for cancer treatment. The company's proprietary platform creates nanomedicines that deliver dual anti-cancer therapies directly to tumors, with a lead product DUO-207 for pancreatic cancer advancing to clinical trials.PITTSBURGH, PA
• Qrono IncQrono Inc. is developing immunotherapies using the Eloquent platform to target antigen-presenting cells and macrophages for cancer treatment. The company focuses on mathematically optimized polymer particles to deliver agents at controlled rates to specific cells.PITTSBURGH, PA